Please login or register first to view this content.
Allergic Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Mepolizumab Cuts Exacerbations in Children With Severe Asthma
OCS-Sparing Effect of Dupilumab for Severe Asthma Maintained
Out-of-Pocket Costs for Epinephrine Auto-Injectors Examined
Asthma Drug Fluticasone Fails as Potential COVID-19 Treatment
Antihistamine Nasal Spray Astepro Allergy Now Available OTC
FDA Clears Barrier-Forming Nasal Spray for Allergic Rhinitis
Azithromycin Improves Outcomes in Poorly Controlled Child Asthma
Microbial Contamination Prompts Recall of Homeopathic Allergy Medicine
How Does Omalizumab Affect Antitussive Use in Patients With Allergic Asthma?
Treating Severe Eosinophilic Asthma: Mepolizumab vs Benralizumab
Hypersensitivity Reactions to Gadolinium-Based Contrast Agents Studied
Asthma, Atopy Risks Up in Offspring Born Via Infertility Treatment
Syringe Malfunction Prompts Recall of Anaphylaxis Treatment
FDA Approves Rx-to-OTC Switch for Nasal Allergy Spray
FDA Approves Disposable Contacts With Antihistamine for Allergic Conjunctivitis
Is Berotralstat an Effective Oral Prophylactic for Hereditary Angioedema?
Low Risk Seen for Second Allergic Reaction to mRNA COVID-19 Vaccine
Trial Evaluating Dupilumab in Difficult-to-Treat Chronic Spontaneous Urticaria Stopped
